Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of endpoints during the analysis of clinical evidence for various types of drug approval processes.

Back to Agenda

Session 3: Research Presentations

Session Chair(s)

René Allard, PhD

Contractor

CTC, Germany

This session will highlight the scientific contributions of new and upcoming investigators involved in study endpoint development, application and analysis.

Speaker(s)

Session Co-Chair

Jean Paty, PhD, MS

IQVIA, United States

Vice President, Patient-Centered Science

Predictors of TMD Persistence: Bringing Science into the Clinic

Carolina Beraldo Meloto, DDS, PhD

McGill University, Canada

Human Pain Genetics Lab, Faulty of Dentistry

Delivering COA Strategies: Improving Our Understanding of the Patient Experience via High Quality Data

Katherine Zarzar

Genentech, A Member of the Roche Group, United States

Head of Agile Execution, Patient-Centered Outcomes Research

Have an account?